Viewing Study NCT06092606


Ignite Creation Date: 2025-12-26 @ 1:19 PM
Ignite Modification Date: 2026-01-14 @ 12:40 AM
Study NCT ID: NCT06092606
Status: UNKNOWN
Last Update Posted: 2023-10-23
First Post: 2023-10-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients
Sponsor: Monyan Pharmaceutical (Shanghai) Co., Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer View
None Heart Failure View
None Arrhythmia View
None Doxorubicin Induced Cardiomyopathy View
None Doxorubicin Adverse Reaction View
Keywords: